Fannin Goldenrod Holdings
Venture capitalActively deployingHouston
Fund manager profile
Fannin Goldenrod Holdings is a venture fund manager based in Houston. SEC filings show 1 venture fund on record, most recently Fannin Goldenrod Holdings I, LLC ($4.6M offering) filed June 2026.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 3 of 3 portfolio companiesBiotech ×3Healthtech ×3Deep Tech ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 23 dated
Goldenrod Therapeutics develops next-generation, brain-penetrant selective PDE4 (phosphodiesterase 4) inhibitors as oral small-molecule drugs for neurological conditions such as Friedreich's ataxia, neurodegenerative diseases, substance use disorders, and pain.
BiotechDeep TechHealthtechHouston, US
Dev Chatterjee(Executive Officer)Leo Linbeck IV(Executive Officer)Mark Worscheh(Executive Officer, Director)
BoardAtul Varadhachary(Executive Officer, Director)Thomas Brenninkmeijer(Director)
Board seatLeo Linbeck III· per SEC Form D · $6.5M raise · filed Jun 2026
BiotechHealthtechHouston, US
Reynolds, III M. Delagado(Director)Benjamin A Hertzog(Executive Officer, Director)Jason J Heuring(Executive Officer)Benjamin A. Hertzog(President & CEO)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
Board seatLeo E Linbeck, III· per SEC Form D · $64M raise · filed Feb 2024
Co-investorsBluebird VenturesScientific Health Development
Pulmotect develops PUL-042, a clinical-stage inhaled therapeutic that stimulates the innate immune system in the lungs to protect against viral, bacterial, and fungal pathogens.
BiotechHealthtechHouston, US
Colin Broom(Executive Officer, Director)
BoardKumar Srinivasan(Director)Atul Varadhachary(Director)Brenton Scott(Director)Mark Worscheh(Director)
Board seatLeo E. LinbeckLeo E. Linbeck IIILeo Linbeck III· per SEC Form D · filed Sep 2024
Co-investorsTexas Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Goldenrod Therapeutics, Inc. · siliconprairienews.com · Jul 8, 2026
Frequently asked questions
- Where is Fannin Goldenrod Holdings located?
- Fannin Goldenrod Holdings is headquartered in Houston, US.